<?xml version="1.0" encoding="utf-8"?>

<rss version="2.0">

<channel>
<title>Stanford HIVDB</title>
<link>http://hivdb.stanford.edu</link>
<description>News and updates about Stanford HIVDB</description>
<lastBuildDate>Tue, 29 May 2012 21:00:00 PST</lastBuildDate>
<language>en-us</language>

<item>
<title>Extensive Update for NRTI and NNRTI Resistance Scores and all Comments</title>
<pubDate>Thu, 29 May 2012 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n36</guid>
<description>
For a more information on the changes to the program please <a href="http://hivdb.stanford.edu/DR/asi/releaseNotes/updates.html#Ver6.2.0_20120529">follow this link</a>.
</description>
</item>

<item>
<title>Extensive Update for NRTI and NNRTI Resistance Scores and all Comments</title>
<pubDate>Thu, 24 May 2012 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n35</guid>
<description>
For a more information on the changes to the program please <a href="http://hivdb.stanford.edu/DR/asi/releaseNotes/updates.html#Ver6.2.0_20120529">follow this link</a>.
</description>
</item>

<item>
<title>Extensive Update for PI Resistance Scores and Comments</title>
<pubDate>Wed, 30 Nov 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n34</guid>
<description>
Most PI resistance scores and comments were updated.  For more details follow <a href="../asi/releaseNotes/updates.html#Ver6.1.1_20111130"> this link</a>
</description>
</item>

<item>
<title>Vast Update for NNRTI Resistance Scores and Comments; scores were added for New Drug - RPV </title>
<pubDate>Mon, 10 Oct 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n33</guid>
<description>
Most NNRTI resistance scores and comments were updated; scores for rilpivirine (RPV) were added and dropped for DLV.  For more details follow <a href="../asi/releaseNotes/updates.html#Ver6.1.0_20111010"> this link</a>
</description>
</item>

<item>
<title>Updated translating rules</title>
<pubDate>Wed, 19 Sep 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n32</guid>
</item>

<item>
<title>Updated the rules from Agence Nationale de Recherches sur le SIDA (ANRS V20)</title>
<pubDate>Wed, 12 Jul 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n31</guid>
</item>

<item>
<title>Updated our classification into Major and Minor mutations; a few scores and comments were also changed</title>
<pubDate>Wed, 29 Mar 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n30</guid>
</item>

<item>
<title>on Mar 29, 2011, we will update our classification into Major and Minor mutations; a few scores and comments will also change</title>
<pubDate>Wed, 22 Mar 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n29</guid>
</item>

<item>
<title>Corrected trigger for comment on unusual mutations at integrase position 72</title>
<pubDate>Wed, 20 Jan 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n28</guid>
</item>

<item>
<title>Updated the rules from Agence Nationale de Recherches sur le SIDA (ANRS V19)</title>
<pubDate>Wed, 12 Jan 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n27</guid>
</item>

<item>
<title>Updated lists of typical protease and RT mutations</title>
<pubDate>Mon, 10 Jan 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n26</guid>
</item>

<item>
<title>Updated criteria for identifying sequences with evidence of Apobec 3G/3F hypermutation</title>
<pubDate>Mon, 10 Jan 2011 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n25</guid>
</item>

<item>
<title>Updated the rules from Rega Institute and Agence Nationale de Recherches sur le SIDA (ANRS)</title>
<pubDate>Tue, 15 Oct 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n24</guid>
</item>

<item>
<title>Added Protease Resistance Combination Scores</title>
<pubDate>Tue, 15 Oct 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n23</guid>
</item>

<item>
<title>Added integrase Resistance Scores</title>
<pubDate>Tue, 01 Sep 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n22</guid>
</item>

<item>
<title>Crystallographic Structures of RT, Protease and Integrase</title>
<pubDate>Wed, 17 Jun 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n21</guid>
</item>

<item>
<title>HIVdb: Updated handling of sequence QA problems</title>
<pubDate>Tue, 06 May 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n20</guid>
</item>

<item>
<title>HIVdb: Adopted new ASI rules compiler</title>
<pubDate>Tue, 06 May 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n19</guid>
</item>

<item>
<title>HIVDB User Guide updated</title>
<pubDate>Mon, 09 Mar 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n18</guid>
</item>

<item>
<title>Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update </title>
<pubDate>Fri, 06 Mar 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n17</guid>
</item>

<item>
<title>HIVdb Comments: minor updates</title>
<pubDate>Tue, 10 Feb 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n16</guid>
</item>

<item>
<title>HIVdb Comments updated extensively</title>
<pubDate>Wed, 21 Jan 2009 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n15</guid>
</item>

<item>
<title>Most PI and NNRTI Resistance Scores and Comments Updated; integrase added; PI drugs renamed</title>
<pubDate>Fri, 04 Nov 2008 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n13</guid>
<description>
 Most PI and NNRTI resistance scores and comments were updated.  The report now accepts sequences with integrase and provides a partial report on the integrase portion.  PI drugs were renamed to include '/r' - FPV/r, IDV/r, SQV/r, LPV/r, ATV/r, TPV/r, DRV/r - to explicitly indicate ritonavir boosting.  For more details follow <a href="../asi/releaseNotes/updates.html#Ver5.0.0_20081104"> this link</a>
</description>
</item>

<item>
<title>A few DRV Resistance Scores and Comments Updated</title>
<pubDate>Fri, 02 May 2008 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n12</guid>
<description>
A few DRV scores and comments were updated. For more details follow <a href="../asi/releaseNotes/updates.html#Ver4.3.6_20080502"> this link</a>
</description>
</item>

<item>
<title>Resistance Scores and Comments Updated</title>
<pubDate>Fri, 29 Apr 2008 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n11</guid>
<description>
A few scores and comments were updated. For more details follow <a href="../asi/releaseNotes/updates.html#Ver4.3.5_20080429"> this link</a>
</description>
</item>

<item>
<title>NNRTI Resistance Scores and Comments Updated: added drug TMC125</title>
<pubDate>Mon, 12 Jul 2007 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n10</guid>
<description>
Scores and comments for TMC125, a new NNRTI drug, were added. For more details follow <a href="../asi/releaseNotes/updates.html#Ver4.3.0_20070712"> this link</a>
</description>
</item>

<item>
<title>Three new programs launched: ART-AiDE, eCARE, and CPR</title>
<pubDate>Tue, 30 Jan 2007 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n9</guid>
<description>
Antiretroviral Therapy - Acquisition and Display Engine (ART-AiDE), electronic Clinical Antiretroviral Resistance Estimator (eCARE), and Calibrated Population Resistance (CPR) were launched.  For more details follow <a href="index.html#n9"> this link</a>
</description>
</item>

<item>
<title>Few PI Resistance Scores Updated</title>
<pubDate>Mon, 04 Dec 2006 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n8</guid>
<description>
A few scores for PI drugs were updated. For more details follow <a href="../asi/releaseNotes/updates.html#Ver4.2.5_20061204"> this link</a>
</description>
</item>

<item>
<title>Resistance Scores and Comments Updated; drugs fAPV and TMC114 renamed</title>
<pubDate>Mon, 21 Nov 2006 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n7</guid>
<description>
A few scores for PI drugs and comments were updated, especially TPV. fAPV was renamed FPV and TMC114 was renamed DRV.  For more details follow <a href="../asi/releaseNotes/updates.html#Ver4.2.4_20061121"> this link</a>
</description>
</item>

<item>
<title>PI Resistance Scores Updated</title>
<pubDate>Mon, 11 Oct 2006 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n6</guid>
<description>
A few scores for PI drugs were updated, especially TMC 114.  For more details follow <a href="../asi/releaseNotes/updates.html#Ver4.2.3_20061011"> this link</a>
</description>
</item>

<item>
<title>ANRS Resistance Algorithm Updated</title>
<pubDate>Mon, 18 Sep 2006 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n5</guid>
<description>
Scores for ANRS resistance algorithm were updated to 2006 July version.  For more details follow <a href="http://pugliese.club.fr/index.htm"> this link to their site</a>
</description>
</item>

<item>
<title>PI Resistance Scores Updated</title>
<pubDate>Mon, 18 Sep 2006 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n4</guid>
<description>
Scores and comments for PI drugs were updated, especially TMC 114.  For more details follow <a href="../asi/releaseNotes/updates.html#Ver4.2.2_20060918"> this link</a>
</description>
</item>

<item>
<title>PI Resistance Summaries Updated</title>
<pubDate>Tue, 22 Aug 2006 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n3</guid>
<description>
PI resistance summary pages have been updated to reflect recently reported data relevant to atazanavir (ATV), tipranavir (TPV), and darunavir (DRV, TMC114). Most of the changes reflect data from salvage therapy trials. Sequences from TPV and DRV treated persons have not yet been submitted to the database. TPV and DRV drug susceptibility data have also not yet been submitted to the database. Researchers who would like to submit such data should contact us at <a href="mailto:rshafer@stanford.edu, syrhee@stanford.edu, tliu@stanford.edu">HIVDB.</a>
</description>
</item>

<item>
<title>Positions available</title>
<pubDate>Tue, 30 May 2006 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n2</guid>
<description>
We are seeking two post-doctoral fellows to perform studies of HIV sequence variation, molecular evolution, population genetics, and antiviral drug resistance; to develop software to assist other researchers performing similar analyses; and to further the development of the Stanford HIV Drug Resistance Database (http://hivdb.stanford.edu).
Candidates should have degrees in biology, biomedical informatics, or statistics and be motivated to innovate and publish. Candidates will have to become highly knowledgeable about the biological and clinical aspects of HIV drug resistance and how the data representing this knowledge is organized in the Stanford database. Candidates will need to be able to write their own programs for querying the Stanford database and for performing statistical and machine learning analyses of data within the Stanford database as well as of data from additional ongoing collaborations. Ideally, one candidate will have a stronger computer programming background and will contribute to improving the database and its tools and another will have a stronger analytic background with statistical skills and an understanding of molecular evolution and population genetics analyses.
Please e-mail your CV, a brief statement, and the names, telephone numbers, and e-mail addresses of three references to <a href="mailto:rshafer@stanford.edu, syrhee@stanford.edu, tliu@stanford.edu">HIVDB.</a>
</description>
</item>

<item>
<title>Letter Written to the FDA</title>
<pubDate>Wed, 25 May 2005 21:00:00 PST</pubDate>
<guid>http://hivdb.stanford.edu/pages/news/index.html#n1</guid>
<description>
Show us the data. To better meet their responsibility, the FDA should encourage pharmaceutical companies to release the data supporting the activity of new HIV drugs against drug-resistant viruses.<a href="hivdb.stanford.edu/pages/news/letter_to_FDA_2005_02_25.html">The full text of the letter &gt;&gt;</a> 
</description>
</item>


</channel>
</rss>
